← Leaderboards
Chien-Te K Tseng
University Of Texas Med Br Galveston
$1,355,173
Attributed
$1,783,571
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $642.6K · FY2007–21$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$1,783,571 · 4
By mechanism
R21$1,059,144 · 2
R01$642,597 · 1
U54$81,830 · 1
Top collaborators
- Eric D Lazartigues1 shared
- Abraam M. Yakoub1 shared
Most similar at University Of Texas Med Br Galveston
Same institution · by research overlap
- Tian Wang$11,943,039
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionVirusPathogenCoronavirus (Genus)RespiratorySevere Acute Respiratory SyndromeFutureRoutePathogenesisLaboratoriesLung DiseasesResponseDisease OutbreaksMortality Vital StatisticsOrganLungDiagnosticPublic Health Medicine (Field)Morbidity - Disease RateBaseLifeCellular TargetingAreaEpithelial Cells
Grant awards (7)
SARS-CoV-2 tropism in the brain and its relationship to COVID-19 pathogenesis$642,597
R01 · FY2021 · HL
Establishment of a Transgenic Mouse Model for Middle East Respiratory Syndrome Co$193,750
R21 · FY2015 · AI · contact PI
Establishment of a Transgenic Mouse Model for Middle East Respiratory Syndrome Co$232,250
R21 · FY2014 · AI · contact PI
Inflammatory Response and SARS Pathogenesis: An in vitro Model$222,197
R21 · FY2009 · AI · contact PI
Inflammatory Response and SARS Pathogenesis: An in vitro Model$222,197
R21 · FY2008 · AI · contact PI
Antiviral Agents as Therapy for SARS$81,830
U54 · FY2008 · AI · contact PI
Inflammatory Response and SARS Pathogenesis: An in vitro Model$188,750
R21 · FY2007 · AI · contact PI